Agnete Witness Præst Jensen

Agnete Witness Præst Jensen is a PhD fellow at the Novo Nordisk Foundation Center for Protein Research within the Faculty of Health and Medical Sciences at the University of Copenhagen. She works in the Olsen Group, focusing on proteomics applications in cancer immunology and immunotherapy research. Her work bridges molecular biology, immunology, and clinical oncology.

Dr. Jensen's research interests center on cancer immunology, with particular expertise in proteomics approaches to understand tumor-immune interactions. Her work investigates mechanisms of immunotherapy response and resistance, particularly in melanoma and pancreatic cancer. She has made significant contributions to understanding T-cell biology, tumor-infiltrating lymphocytes, and combination immunotherapy approaches. Her research spans from basic molecular mechanisms to clinical applications, with several publications in high-impact journals.

Analysis of her publications reveals a strong focus on translational cancer research, particularly at the intersection of proteomics and immunotherapy. Her work demonstrates expertise in both experimental design and clinical data interpretation, with publications spanning basic science, review articles, and clinical trials. She frequently collaborates with leading researchers in the field of immuno-oncology at the University of Copenhagen and beyond.

Dr. Jensen has established productive collaborations across multiple institutions, as evidenced by her co-authorship on studies involving clinical trials and mechanistic research. While specific grant information isn't available in the provided text, her publication record suggests active participation in funded research projects related to cancer immunotherapy.